Agilon Health, Inc. (NYSE: AGL) Faces Securities Class Action Lawsuit
On January 8, 2026, Bernstein Liebhard LLP announced that a significant securities class action lawsuit has been filed on behalf of investors in Agilon Health, Inc. (NYSE: AGL). Shareholders who acquired shares between February 26, 2025, and August 4, 2025, may be eligible to join the class action. This legal step highlights concerns over potential misrepresentations related to the company's 2025 financial guidance.
Details of the Class Action Lawsuit
The lawsuit alleges that Agilon Health, Inc. misrepresented critical information regarding its projected guidance for the fiscal year 2025. These misrepresentations may have significantly impacted investor decisions, resulting in losses for those who purchased shares during the specified period.
Shareholders interested in participating in the class action must file relevant documentation by March 2, 2026. It is crucial to note that while serving as lead plaintiff is an option, it is not a prerequisite for participating in any potential recovery from the lawsuit.
How to Participate in the Class Action
Investors looking to engage with the ongoing litigation can await updates or submit inquiries for more information. Key contact details include:
- Email: pallocco@bernlieb.com
- Phone: (212) 951-2030
Additionally, Bernstein Liebhard LLP operates on a contingency fee basis, meaning that shareholders need not pay any fees or expenses unless their case is successful.
About Bernstein Liebhard LLP
Founded in 1993, Bernstein Liebhard LLP has established a strong track record, recovering over $3.5 billion for its clients. The firm is well-known for representing both individual investors and large public and private pension funds, working diligently to protect assets and pursue litigation when necessary.
With its extensive experience, the firm has been featured on The National Law Journal’s “Plaintiffs’ Hot List” thirteen times and has been recognized in The Legal 500 for sixteen consecutive years—including its efforts to assist shareholders in cases involving companies like Agilon Health, Inc. (NYSE: AGL).
Conclusion
The filing of this securities class action lawsuit against Agilon Health, Inc. (NYSE: AGL) serves as a reminder for investors to remain vigilant concerning the accuracy of corporate disclosures. As the case unfolds, affected shareholders are encouraged to consider their legal options and engage with Bernstein Liebhard LLP for guidance.